(3-010) 2020 Heart Disease Deaths Compared to Medicare Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease Inhibitor (PCSK9i) Prescription Rates

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Ambulatory Care

Co-Author(s): Cherry Ann Aki, Bryce Fukunaga

Primary Author(s)

Katrina G. Heyer
Student
University of Hawaii at Hilo The Daniel K. Inouye College of Pharmacy, Hawaii